Is Argent Biopharma Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Argent Biopharma Ltd (RGT.AX) is currently classified as NOT HALAL as of September 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Argent Biopharma Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Argent Biopharma Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Argent Biopharma Ltd?

Muslim investors may consider investing in Argent Biopharma Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Argent Biopharma Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Argent Biopharma Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Argent Biopharma Ltd updated?

The Shariah compliance status of Argent Biopharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Argent Biopharma Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Argent Biopharma Ltd?

You can check the latest Shariah compliance status of Argent Biopharma Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

RGT.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: September 14, 2024

Report Source: 2024 2nd Quarter Report

Argent Biopharma Ltd. Stock Analysis RGT.AX

Australia Health Care Nano Cap Report: Q2, 2024

Argent BioPharma Ltd. engages in the production of medical marijuana. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2006-12-21. The Company’s assets, CannEpil and CimetrA, target immune dysregulation in drug-resistant epilepsy and cytokine-driven inflammatory disorders, respectively. The Company’s proprietary delivery technologies enhance penetration across the blood-brain and alveolar-capillary barriers, supporting differentiated efficacy and composition-of-matter protection. The company focuses on urgent unmet needs in the central nervous system (CNS) and systemic inflammation. Its product pipeline includes CimetrA, CannEpil, CogniCann and others. CannEpil is a refractory epilepsy seizure control treatment. CogniCann is an investigational oral spray developed by the Company to help manage symptoms associated with dementia and Alzheimer’s disease. The firm has a patient base in Australia, the United Kingdom, Brazil, and Ireland.

Key Statistics of Argent Biopharma Ltd (RGT.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.04AUD0.04

Today's Open

AUD0.04

Volume

8200.00

P/E Ratio (TTM)

52 Week Range

AUD0.03AUD0.32

Market Cap

4.44M

Avg. Volume

40.37K

Dividend Yield

Financial Metrics & Statements of Argent Biopharma Ltd (RGT.AX)

FAQ's for Argent Biopharma Ltd (RGT.AX)

According to Musaffa’s Shariah screening methodology, Argent Biopharma Ltd (RGT.AX) is currently classified as NOT HALAL as of September 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.